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Introduction
Adolescent girls and young women (AGYW), ages
15–24 years, account for 75 percent of young
people in sub-Saharan Africa who are living with
HIV.1 As many as 7,000 new infections a week
are occurring among the most vulnerable AGYW
in Eastern and Southern Africa; AIDS is the
leading cause of death for adolescent girls ages
10–19 in Africa.1 In sub-Saharan Africa, women
acquire HIV five to seven years earlier than men,
and young women are at an increased risk of HIV
acquisition compared to young men.1 To date,
prevention efforts have not had the maximum
impact on AGYW’s risk of acquiring HIV.2 The Joint
United Nations Programme on HIV/AIDS (UNAIDS), highlights gender-based violence, limited
access to health services, limited education, and
policies or systems that exclude young women as
the key contributors to AGYW’s increased vulnerability to HIV.1 The introduction of pre-exposure
prophylaxis (PrEP) within the context of a comprehensive HIV prevention package, would make
a new HIV prevention option available for AGYW,
offering them an opportunity for more control of
their sexual health.
Oral PrEP, the use of antiretroviral (ARV) medications by HIV-negative persons to prevent the
acquisition of HIV, is a new biomedical intervention that has the potential to substantially reduce
HIV acquisition among those most vulnerable
to HIV. Recent evidence indicates that PrEP is
efficacious in different populations at high risk of
HIV acquisition—in studies with high adherence,
HIV infection risk was reduced by 70 percent.3
Trial results have shown that oral PrEP in men
who have sex with men significantly reduces the
risk of HIV acquisition by as much as 92 percent
when taken as prescribed.4 Results on the efficacy of PrEP for women, aged 18 and older, are

Keeping adolescent girls and
young women HIV- and AIDS-free
is critical for their well-being and
health, the health of their families
and communities, and their
countries’ future.
—PEPFAR
mixed, most likely associated with different levels
of adherence.3 It also appears that women need
to take daily oral PrEP for a longer period of time
than men before they acquire protective levels
of the drug in their body.2,5-7 For young women,
emerging data show that when women know that
PrEP is effective, they use it more consistently.8
Given their increased vulnerability to HIV infection, PrEP could have a significant impact on HIV
acquisition among AGYW, if they are able to effectively access and use PrEP. Thus, we need to fill
existing gaps in knowledge about how different
stakeholders will perceive PrEP, how AGYW will
use it in real-world settings, and how to design
and implement effective service delivery models.
Currently there is great interest and momentum
in bringing PrEP to populations at substantial risk
of HIV, including AGYW. Decreasing infections
among young people is a key aspect of the global
ALL IN intitiave to accelerate the fight against
AIDS for adolescents. Further, the World Health
Organization (WHO)4 recommends the availability
and use of oral PrEP to mitigate HIV acquisition.
The DREAMS (Determined, Resilient, Empow-
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Countries will need to develop a
vision for how PrEP for AGYW fits
into their overall HIV prevention
landscape and how to address
challenges associated with its
introduction.
ered AIDS-free, Mentored, and Safe) initiative—a
partnership between the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the Bill &
Melinda Gates Foundation, and Girl Effect, plus
Johnson & Johnson, Gilead Sciences, and ViiV
Healthcare9—aims to significantly reduce new
HIV infections among AGYW in 10 countries in
sub-Saharan Africa by providing a core package
of interventions to AGYW residing in areas with
high HIV prevalence. The provision of PrEP is currently part of the prevention package for some of
the DREAMS countries, and is being considered
by several others. Under the DREAMS mandate
and other global efforts, new programmatic
strategies for introducing this innovative product
in real-world settings are being developed and
implemented. There is an urgent need for implementation science to complement biomedical,
clinical, and product marketing research in order
to appropriately introduce PrEP to AGYW.
The equitable and ethical introduction of this
new biomedical intervention has to take into
account the particular vulnerabilities that AGYW
may face; these include, but are not limited to,
legal and policy constraints affecting access
and ability to consent to sexual and reproductive
health services, stigma around AGYW sexuality,
power dynamics between AGYW and parents and
partners, experiences of violence and coercion,
and individual capacity to assess HIV risk.10
Further, the past introduction of a number of
health technologies for women (e.g., human

papillomavirus vaccine, emergency contraception) have highlighted women’s concerns around
how a product works, whether it has the potential
to cause harm, whether it will jeopardize fertility,
and whether it will influence relationships.11 As
countries consider and plan to introduce and
expand PrEP implementation under DREAMS
and other initiatives, there is a need to carefully
examine the individual behavioral factors as well
as the structural and sociocultural factors that
may influence PrEP acceptability, uptake, and
adherence among AGYW. Countries also will need
to develop a vision for how PrEP for AGYW fits into
the overall HIV prevention landscape and how to
address challenges associated with its introduction,11 such as determining the:
• Most appropriate sub-populations of AGYW
for using PrEP, given the nature of the HIV
epidemic within the country.12
• Feasibility of introducing PrEP to AGYW in
a safe and ethical way that supports their
human rights.
• Ability of health services to reach the most
vulnerable AGYW.
• Influence of service providers, partners,
families, and communities on AGYW’s
acceptance of PREP.
• Willingness of AGYW to utilize and adhere to
PrEP.
• Policy and service delivery issues that arise in
the early stages of new product introduction.
• Best ways to introduce PrEP to AGYW into
existing health care systems.

PURPOSE OF THE DOCUMENT
This document was developed by the Population
Council, with support from the Bill & Melinda
Gates Foundation, to provide DREAMS country
teams with practical guidance on building evidence to guide PrEP introduction for AGYW.
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The primary audiences for this document are
health policy makers and program planners
who will be making decisions about how PrEP is
introduced to AGYW and the researchers who will
assess AGYW’s specific needs and experiences.
Our aim is to complement emerging global
guidance on PrEP1 and on-going work regarding
delivery platforms, marketing, and policy and
regulatory frameworks for PrEP introduction more
generally. We focus on examining the factors
that influence informed choice, demand, and
use of PREP by young women and that influence
client-provider interactions. Further, we hope this
document can serve as a useful guide to gather
data on user, community, and provider perspectives as countries move from introduction to
broad-based implementation of PrEP.
This practical guidance document is informed by
the Population Council’s work on HIV prevention
product introduction for women11,12 and builds
on our commitment to understanding whether,
when, how, and under what circumstances ARVbased prevention would be beneficial for AGYW.

ETHICAL CONSIDERATIONS
Depending upon the types of data to be
collected, and for what purpose (for program development versus research publication), the data
collection proposed in this document may need
to undergo an ethical review, may be exempt from
an ethical review, or may be considered to not
be research (and therefore not require an ethical
review). As guidelines for ethical reviews vary by
setting and organization, it is recommened that
you check with your local ethical/institutional
review board to determine the best way forward.

Regardless of whether the data collection proposed in this document must undergo an ethical
review, it is the responsibility of the research
team to fulfill several obligations and ensure
safeguards in planning and conducting the
research, as well as reporting research findings.
Specifically, ethical standards need to be met for
maintaining the dignity and welfare of all participants; protecting them from harm, unnecessary
risk, or mental and physical discomfort; and
ensuring that respondents are not being unduly
influenced or induced into participation in the research. Further, ethical guidelines pertaining to
the accurate and appropriate use of data should
be maintained by researchers and others using
the data. These issues are particularly important
to consider when conducting research with minors (those below the age of legal consent) and
marginalized populations.
Several available resources provide guidance
on research with minors and should be consulted during the design and development of
this research. Some examples include http://
childethics.com and http://www.popcouncil.org/
uploads/pdfs/horizons/childrenethics.pdf.
Before data collection, all participants should be
given information on PrEP attributes. UNAIDS’
“Oral pre-exposure prophylaxis—Questions and
answers” is a brief resource guide (published in
2015) that contains answers to pertinent questions about PrEP, its use, and implementation.
The guide can be downloaded at http://www.
unaids.org/en/resources/documents/2015/
Oral_pre-exposure_prophylaxis_questions_and_
answers. The information given should cover who
is eligible to take PrEP, route of administration,
frequency of use, side effects, and the need for
HIV testing.

The WHO is currently developing comprehensive global implementation guidelines for PrEP.
1
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STRUCTURE OF THE
DOCUMENT
This guidance document is divided into five sections, as follows:
Section 1: Provides a framework for PrEP introduction to AGYW.
Section 2: Focuses on the key actors that influence AGYW’s choices—AGYW themselves, service
providers, male partners, parents and guardians,
and policy makers, respectively. For each type
of actor, the section provides a brief rationale
to reaching this key actor, important domains to
investigate for guiding PrEP introduction, recommended data collection methods, and illustrative
questions per domain.
Section 3: Describes additional data collection
techniques and methods to gain a deeper perspective of participants’ views.
Section 4: Provides practical advice for conducting analysis.
Section 5: Provides an overview of practices to
foster research utilization.
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SECTION 1

DEVELOPING A PREP INTRODUCTION
STRATEGY FOR AGYW:
A CONCEPTUAL FRAMEWORK
In this section we present a framework (Figure
1, page 7) that highlights the range of players,
relationships, and contextual factors that can
affect AGYW’s health-seeking behaviors and their
PrEP uptake and use. This framework is useful to
consider when designing PrEP introduction strategies. It positions young women in the context
of their partner, peers, family, health providers
and services, social values/community context,
and broader scientific knowledge about PrEP—all
of which can interact and influence, sometimes
positively and sometimes negatively, the choices
that AGYW make or are able to make. 2,10,13-17
The framework consists of two sides that interact, demonstrating the intricacies and dynamic
aspects of PrEP introduction among AGYW. The
right side of the framework focuses on the main
factors that determine the feasibility of effective
introduction of quality PrEP services for AGYW.
These include the scientific context, political landscape, health system infrastructure, and provider
dynamics. For instance, regulatory guidelines
that identify target populations for PrEP can have
major implications for who can access PrEP.
Similarly, decisions around consumer drug costs
and service delivery platforms can have important implications for AGYW. Service providers are
gatekeepers of new medical products and their
knowledge, attitudes, and perceptions will determine whether and how they offer PrEP to young
women as an HIV prevention method. An as-

sessment of these factors will determine whether
health systems have the capacity to deliver PrEP
safely and effectively to AGYW.
The left side of the framework focuses on the
main factors that determine whether young women are able to make informed decisions around
PrEP uptake and its effective use. Key factors
that influence informed choice, uptake, and use
of PrEP include the community context, family
dynamics, partner dynamics, and AGYW characteristics. For instance, broader community-level
knowledge about PrEP, parental consent for PrEP
use, and experiencing violence within sexual relationships are likely to influence AGYW’s decisions
about PrEP. Further, young women’s access to education, information, and social support, and their
own HIV risk perceptions are likely to significantly
influence PrEP uptake and use. Examining these
factors will highlight key barriers and facilitators to
PrEP uptake, use, and adherence among AGYW.
The two sides of the framework are connected to
illustrate the interplay between them, which we
need to fully understand if PrEP for AGYW is to be
realized. AGYW and service providers are depicted
at the center of the framework to demonstrate the
relative importance of
provider-AGYW interactions. Consequently, it will
be important to engage both service providers and
AGYW in developing programs for PrEP introduction.
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The factors and relationships depicted in the
framework extend beyond the initial phases of
PrEP introduction and should be examined as
part of ongoing efforts to monitor safety, adherence, and service quality.
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SECTION 2

ENGAGING KEY ACTORS:
KEY DOMAINS, METHODS, AND
QUESTIONS
ADOLESCENT GIRLS AND
YOUNG WOMEN
The success of PrEP as an HIV prevention intervention among AGYW is largely dependent on
its successful uptake and adherence by AGYW,
the end-user of the drug. A critical assessment
of AGYW’s knowledge, attitudes, perceptions,
current sexual and reproductive health behaviors,
social context, and engagement with the health
care system will aid in identifying and reaching
AGYW who are most at risk of acquiring HIV, determing challenges associated with acceptance
and uptake, and identifying opportunities to support AGYW in protecting themselves against HIV.
The assessment needs to start with clarity
around the AGYW sub-population to be reached.
Once the focus AGYW group is decided, then the
specific actors who might play a role in influencing those AGYW’s decisions about PrEP can be
effecively identified.
This section provides guidance on how to undertake such an assessment to inform a PrEP
introduction strategy for AGYW that reduces barriers while enhancing facilitators to uptake and
adherence.

Population
HIV vulnerability varies within the population of
AGYW. For example, studies have shown that
female sex workers (FSWs) are at a considerably
higher risk of acquiring HIV when compared to
the general AGYW population.18 The nature of the
epidemic will determine relevant sub-populations
of AGYW in a given setting. Program planners are
encouraged to utilize existing epidemiological
evidence and literature to identify the subpopulations who are the most vulnerable to HIV
within their setting and who should be included
in an assessment to understand the barriers and
facilitators to uptake and adherence.
An understanding of these sub-populations’
barriers and facilitators aids in tailoring a PrEP
introduction strategy. See Box 1 for potential
sub-populations to include in an assessment.

Key Domains
PrEP Attributes, Acceptability and Potential Use:
There are several attributes of PrEP, such as frequency and route of administration, side effects,
and the need for frequent HIV testing, that may
influence AGYW’s likelihood to use and adhere to
it. Additionally, there is a need to assess AGYW’s
attitudes and perceptions of PrEP after learning
about how it works. The evidence shows that
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BOX 1
Potential sub-populations of
AGYW
Female sex workers
AGYW who engage in transactional sex
AGYW who engage in cross-generational
sex
AGYW with multiple concurrent partners
Married AGYW
Orphaned AGYW
Out-of-school AGYW
AGYW living in hotspots
AGYW with HIV-positive sexual partners
AGYW who perceive themselves to be at
high risk of HIV acquisition

users gain the greatest benefit of PrEP with very
high adherence.4 Thus, understanding the factors, such as side effects, testing requirements,
and drug supply, that are likely to influence adherence are also important to assess.
Risk Perception and Compensation: Using and
adhering to PrEP is influenced by AGYW’s perceptions of their risk for acquiring HIV; if an AGYW
believes she is at low risk of acquiring HIV, it is
unlikely that she will access, use, and adhere
to PrEP. On the other hand, there is concern
that AGYW who perceive themselves at risk of
acquiring HIV and do use PrEP, will increase
risky sexual behaviors and reduce existing
risk-reduction behaviors, which is known as “risk
compensation.”19 There is little evidence of risk
compensation, but understanding AGYW’s risk
perceptions and potential for risk compensation
prior to PrEP introduction can aid in developing

strategies to make risk salient to AGYW and maximize motivations for prevention.2
Gendered Power Dynamics: Inequitable gender
norms and gendered division of power within
sexual relationships have been shown to play an
important role in AGYW’s ability to accept and
adopt sexual and reproductive health interventions, including contraceptive use and condom
use.2,20 Thus, PrEP introduction strategies should
take into account how gendered power dynamics
and control over decision-making may influence
perceived risks and benefits of PrEP, which impacts uptake and adherence.
Stigma and Social Acceptability: The willingness
of AGYW to use and adhere to PrEP will greatly
depend on social understandings, including
whether it is seen as an effective, healthy option
and a socially acceptable strategy for HIV prevention.21 Additionally, stigma has been shown
to influence PrEP uptake and adherence in a
few studies because PrEP use might lead others
to believe users are engaged in high risk sex or
are HIV positive since PrEP is an antiretroviral.21
Understanding PrEP-related stigma and social
acceptability in a given setting is important for
designing introduction strategies for AGYW.
Service Delivery Models and Strategies: The
successful uptake of PrEP by AGYW will be
dependent on the service environment where it
is offered and whether AGYW feel comfortable
accessing services from these locations. PrEP
introduction strategies should consider the feasibility of offering PrEP in diverse settings based on
AGYW’s preferences.

Methods
We recommend two methods to assess the
challenges and opportunities associated with
PrEP acceptance, uptake, and adherence among
HIV-negative, sexually active AGYW: focus group
discussions (FGDs) and in-depth interviews (IDIs).
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Use IDIs to gain information on topics that are
sensitive in nature, such as power dynamics
within sexual relationships, and when seeking
information about personal perceptions, attitudes, and behaviors. For each sub-population, a
minimum number of IDIs is four to six. Program
planners might also consider if groups should
be conducted in various geographical regions in
order to gain a broader overview of barriers and
facilitators.
Use FGDs to generate broad overviews of PrEP
acceptance, uptake, and adherence to gain information about social factors that would influence
PrEP acceptance, and to brainstorm and generate ideas on how to increase acceptability and
uptake. Consider conducting FGDs after a few
IDIs have been completed to determine whether
some themes from the IDIs are present within a
larger group of AGYW. For each sub-population,
an ideal focus group size is between 6 and 10
participants and the assessment should include
at least two to three groups of participants.
Again, program planners might also consider if
groups should be conducted in various regions in
order to gain a broader overview of barriers and
facilitators.
Eligible AGYW are those who are HIV-negative. To
draw the sample, purposefully select AGYW from
a variety of settings where specific sub-populations are found in order to gain comprehensive
information. Partnering with community-based
organizations (CBOs)/nongovernmental organizatons (NGOs) who work with and are trusted
by the different sub-populations of AGYW can
provide detailed insights into where and how to
recruit respondents. Healthcare settings, such
as antenatal and family planning clinics, are one
easily accessible location to recruit AGYW. AGYW
recruited from these sites can also assist with
the recruitment of their peers who might not
access these services. Venues where AGYW are
known to frequent can also serve as good recruitment sites, such as CBOs, schools, youth clubs,
markets, shopping centers, bars, clubs, and large

community events. The staff of NGOs can provide
insights into where sub-group populations, especially marginalized populations, such as young
FSWs, could be reached. Another approach that
works well with marginalized populations is snowball recruitment or sampling. This entails the
interviewers asking the participants of initial IDIs
and FGDs to help connect them to their peers.
Ideally, FGDs and IDIs should be conducted
by trained facilitators who are drawn from the
participating sub-population or by individuals who
can develop good rapport with participants, such
as staff of CBOs. For breadth and depth, AGYW
participating in IDIs should not participate in
FGDs. Rather, the research team should assess
the comfort level of each potential participant to
determine whether to assign her to an FGD or an
IDI. FGDs should be homogenous within sub-populations of AGYW; that is, all participants for each
FGD should be a member of the same sub-group
(e.g., only FSWs should be in a FSW FGD). It is
also important that FGDs and IDIs are conducted
in safe spaces to ensure safety and confidentiality.
While these data collection strategies will inform how to effectively introduce PrEP to AGYW,
continued monitoring of the domains after PrEP
introduction will be needed to determine uptake and adherence. As such, a monitoring plan
should be developed.

Questions
Note: Some of the questions noted below will not
be appropriate for group discussions due to their
sensitive nature.

PrEP attributes, acceptability,
and potential use
• Had you heard about PrEP before today? (If
a FGD, ask for a show of hands and record
number) If so, what had you heard, and who
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or where did you hear it from? (Probe for
health care provider, school, community-based
educator, family/friends, PrEP user)
• What do you see as the benefits of PrEP for
you personally?
 What about for other young women like
you?
• In order for PrEP to work, people have to take
a pill every day. What do you think about
having to take a pill every day?
 What do you think other young women like
you would think about taking a pill every
day?
• Another way that is currently being explored
for people who want to take PrEp involves
taking a series of pills right before having
sex and then continuing to take pills shortly
after having sex. What do you think about
this method of taking PrEP, which provides
protection just for that/those sexual
encounter(s). Which of these ways are you
more interested in, and why?
 Of the two methods—taking a pill every day
or taking it before/after sex—which method
would you prefer, and why?
 Which method do you think young women
like you would prefer and why?
• Based on what you learned today/have heard
before, how would the following things about
PrEP influence your decision and that of other
young women like you about taking PrEP?
(Facilitators can also lead the respondents
through a listing and ranking exercise to
identify major and minor concerns.)
 The level of effectiveness in preventing HIV
transmission
 Having to take a pill every day
 Possible side effects of PrEP (which ones?)
 Having to pick up a supply on a regular
basis
 The requirement to be tested for HIV every
two to three months

 The requirement to receive counseling
about adherence on a regular basis
(adherence means taking medications in
the correct amount, at the correct time,
and in the way they are prescribed)
 The color of the pill
 Having to store or keep the pills
 The cost of the pill
 Any other concerns
• How would it make you feel to start taking
PrEP? (Please describe)
• Are there any cultural traditions in your
community(ies) about taking medications that
would make young women more or less likely
to take PrEP? (Describe)
• What if you were given something to motivate
you to take PrEP?
• What should the incentive be? (Probe for
money, airtime)
• If PrEP became available in your community
in the next week, how willing would you be to
start taking it immediately?
• What if PrEP became available within the next
six months, how willing would you be to start
taking it immediately?
• Earlier we talked about certain aspects
of PrEP, including possible side effects
and requirements to be tested, receiving
adherence counseling, and picking up a pill
supply on a regular basis. Do you think any of
these things would make it more difficult to
continue to take PrEP every day, over months
or years? Which? (please describe)
• If you started to take PrEP, what would help
you continue to take it every day, over months
or years? (Probe and ask participants to rank
from most to least helpful for: close location of
PrEP services, support from partner, support
from friends and family, other people you
know taking PrEP, mobile phone text or call
reminders, attitude of health facility staff,
lower cost.)
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• How easy or difficult do you think it would
be to incorporate taking a daily pill into your
current routine? Why?
• What factors would affect your ability to take
PrEP on a daily basis? What factors would
enhance your ability to adhere to a daily PrEP
regimen? (Probe: product storage, dosing
when away from home, peer support, other
support measures like SMS reminders or
adherence counseling, fear of others finding
out or of GBV.)

Gendered power dynamics
• Please tell me about instances where you
have discussed avoiding/preventing HIV
with your primary sexual partner? (Probe on
condom use)
 Do you have additional sexual partners,
and if so how many?
 Does your primary sexual partner have
other sexual partners (that you are aware
of)?
• How do your sexual partner’s opinions
about you using products (e.g., condoms,
contraceptives) to prevent HIV and pregnancy
affect your decisions to use them?
• How might you discuss your desire to start
taking PrEP with your sexual partner?
• How would your primary sexual partner’s
opinion about PrEP affect your decision to
take it?
 What if he agrees? What if he disagrees?
 Is your sexual partner currently taking
PrEP?
• If you considered taking PrEP without telling
your primary sexual partner, what impact
might this have on your relationship?
 How might he react if he found out?
• What would be some reasons why you would
not tell your partner that you are interested in
taking PrEP or you were taking PrEP?

Risk perception and
risk compensation
• How likely do you think it is that you will get
HIV? Why? (Probe for number and types of
sexual partners, frequency of sex, condom
use, knowledge of HIV status of partner)
• How might your concerns about getting HIV,
influence your interest in starting to take
PrEP?
• How might using PrEP change the type and
number of sexual relationships you have?
• How might the use of PrEP influence condom
use with your sexual partners?

Stigma and social acceptability
• What do you think your friends know about
PrEP? How might their opinion about PrEP
influence your decision to use PrEP?
• What do you think your parents/guardians
know about PrEP? How might their opinions
influence you?
• What about other leaders in your community
(e.g., teachers or religious leaders)? What kind
of influence do they have on your opinions and
decisions about PrEP?
• How do other people in your community think
about ARVs and people who take ARVs? How
do they treat people who take ARVs?
 In what way would these views influence
your decision about whether to use PrEP (If
so, how)?
• If you knew a friend was taking PrEP, what
would you think of her?
• If you started to take PrEP, how likely would
you be to share this information with your
peers (or family members)? What factors
would encourage/discourage you to do so?

Service delivery strategies and models
• Where would you prefer to go for PrEP services
and to collect PrEP pills? (Probe for health
clinic, ARV clinic, youth-friendly clinic/service,
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pharmacy, private provider, family planning
clinic, NGO) What are the pros and cons of
each place?
• What do you think about the idea of PrEP
being delivered outside of a health facility
(such as at school or at your home)? What
might be the barriers and benefits to this
different approach?
• What is the best way to reach adolescent girls
and young women with messages about their
sexual health (Probe for radio, television, peer
educators, health care providers, posters,
flyers, social media, cell phone texts, etc.)?
• If you were going to create a campaign to
encourage young women like yourself to
consider using PrEP to reduce their risk of
getting HIV, how would you describe what PrEP
is and how it works (in your own words)?
• What information about PrEP should be
emphasized in communication campaigns?
What should not be emphasized?
• For young women who start on PrEP, what is
the best way to encourage them and remind
them that they need to take the medication
and to get tested for HIV every few months?
(Probe for phone call reminder, text message
reminder, letter)
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SERVICE PROVIDERS
Service providers of varying skill levels and
service settings serve as the gatekeepers of
new technologies requiring a prescription. PrEP
introduction efforts depend on service providers
and the health systems within which they work
having the capacity to deliver the product safely
and effectively to AGYW. A critical assessment of
service providers’ knowledge, attitudes, beliefs,
concerns, competencies, and behaviors is needed in the following areas: 1) the introduction of
a new technology into their service system and
ability to provide quality care; 2) the introduction
of an ARV-based product to AGYW; and 3) the provision of sexual and reproductive health services
to AGYW in general.
This section provides guidance on how to undertake such an assessment to determine effective
provision of quality PrEP services for AGYW. This
assessment should provide insight into what
strategies are needed for successful introduction
and ultimately, uptake and adherence by AGYW.

Population
The assessment should be conducted with appropriate cadres of service providers in a variety of
health service settings to ensure appropriate
counseling, provision, testing, resupply, and
follow-up of AGYW. The assessment should generate insights from a variety of service providers
who may be eligible to provide PrEP to AGYW. The
selected providers will vary in a given setting. A
potential list of service providers to include in the
assessment is provided in Box 2.
It also is important to determine which service
delivery settings would be most appropriate and
feasible to reach different sub-populations of
AGYW with PrEP. Therefore, service providers included in the assessment should be drawn from
the diverse service delivery settings that exist

BOX 2
Potential health service
providers
Clinic administrators
Doctors and medical officers
Private medical practitioners
Nurses
Counselors
Lab technicians
Outreach workers
Pharmacists
Peer educators

within a given context. A potential list of service
settings is provided in Box 3.
The information gathered from service providers
and AGYW can help determine the feasibility of
introducing PrEP, and if feasible, the best service
delivery settings and service providers to provide
PrEP.

Key Domains
PrEP Knowledge, Attitudes and Perceptions:
Recognizing the gatekeeper role that service
providers play in influencing service delivery and
uptake, it is important to assess their knowledge, attitudes, and perceptions. Training on
the technical aspects of PrEP introduction and
use can be undermined by providers who hold
negative attitudes and viewpoints toward PrEP.
Existing research, mainly from developed country
settings, shows that providers have a number of
concerns that would influence their prescribing
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BOX 3
Potential service settings for
delivering PrEP
Public-sector health centers and hospitals
Private medical practice health centers and
hospitals
Non-governmental organizations
Faith-based organizations
University-based health clinics
Youth-friendly health service locations
HIV counseling and testing sites
STI prevention and treatment sites
Family planning & reproductive health sites
Maternal health settings
Pharmacies
Gender-based violence counseling sites
Mobile health services

of PrEP, including drug resistance, drug-related
toxicities, the potential for funds to be diverted
from HIV-related behavior change programs, and
risk compensation.11,21 Thus, the findings from an
assessment will help program planners determine the providers’ training needs to make PrEP
introduction effective.
Stigma: Stigma from service providers within service delivery settings is an important component
to assess and understand.21,22 The contraception
literature shows that service providers serve as
barriers to uptake and use because many refuse
to counsel about and provide contraception to
adolescents due to their attitudes and beliefs
about adolescent sexual activity.22 Therefore, it

will be necessary to address stigma within service delivery settings to reach and protect AGYW
if PrEP introduction is to be feasible and successful. A failure to assess and subsequently address
service providers’ biases can significantly impede
AGYW access and uptake of PrEP.
Legal and Ethical Considerations: There are
many ethical and legal considerations that must
be assessed so that those at high risk of acquiring HIV and most likely to benefit from PrEP can
access this promising intervention. For example, in some settings adult consent is required
in order for adolescents under the legal age of
consent to receive certain HIV services and treatment; PrEP is likely to be included in the list.10
The breach of the child’s right to confidentiality
and access to care (as many vulnerable youth do
not feel comfortable disclosing their behaviors to
adults) are among the ethical concerns surrounding the need for adult consent. Safety is both
a legal and ethical concern as some behaviors
are illegal (e.g., selling sex) and AGYW may avoid
accessing services. Another example is the obligation of service providers to report adolescents
who are below the legal age of consent requesting PrEP or to report behaviors of adolescent key
populations in settings where certain behaviors
are illegal.10 Therefore, service providers’ knowledge of existing consent laws and other legal
considerations, how they interpret and implement laws, how existing laws affect the provision
of services to AGYW.
Service Delivery Considerations: PrEP introduction and ultimately the potential benefits it may
offer to AGYW may be severely undermined if
health services lack the capacity and the ability
to meet the technical requirements of PrEP.11,22
These include the existence of written medical
guidelines, protocols, and standards at the service delivery sites; the possession of necessary
equipment and supplies (e.g., HIV test kits); existence of adequate space to store products; and
having the human resources to provide PrEP. It is
also important to gain service providers’ insights
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into which service delivery settings are most appropriate and prepared to provide PrEP to AGYW
to increase likelihood of acceptance, uptake, and
adherence.
Service Access and Quality of Care: Provider-patient interactions influence service access
and quality of care provided. Adherence is a
particularly challenging aspect of PrEP and
there is need to develop strategies to effectively support and measure adherence.11 Provider
counseling of AGYW on correct and consistent
use of PREP is a key strategy for fostering adherence.23,24 Therefore, the existing capacity of
service providers and service delivery systems
to provide high quality counseling needs to be
assessed. These results will inform the training
of providers, and can be particularly helpful in
dissipating providers’ reluctance to adopting new
interventions that require special counseling and
educational skills they do/may not possess.23,24
Outside of counseling, a general assessment of
how providers interact with AGYW is important to
understanding how to improve the quality of care
provided. To create the most effective training,
the assessment should solicit providers’ insights
into the best counseling messages for AGYW and
their own training needs.23

Methods
We recommend two strategies to assess the
capacity of health care providers within different
service delivery systems for PrEP introduction
and roll-out: IDIs and surveys. Use IDIs to gain
information on individual service provider’s
knowledge, attitudes, beliefs, concerns, perceived competencies, and experiences providing
care to AGYW in a variety of health service
settings. IDIs are preferred to FGDs because they
allow for the exploration of sensitive (e.g., personal beliefs about adolescent sexuality, experiences
with youth clients) and non-sensitive (e.g., service delivery staff requirements for PrEP) topics.

Furthermore, the interviews can provide in-depth
information on factors relevant to distinct service delivery settings, such as client flow, patient
intake systems, and referral mechanisms. A
minimum of two to three IDIs should be conducted per service provider type per service delivery
setting type. Program planners must also consider regional variations.
One good option is to recruit and train service
providers currently offering HIV services to facilitate the IDIs because they will be knowledgeable
and aware of the critical issues in HIV prevention in their country. Being interviewed by peers
who understand their daily experiences will also
encourage service providers to be honest about
their perspectives of PrEP. To encourage service
providers to participate in the interviews, ensure
confidentiality of their responses by anonymizing
their transcripts and assure them that responses
provided will not jeopardize their employment.
To complement the richness of the IDIs, the
assessment should also include a survey administered to a large cross-section of service
providers in a variety of service delivery settings.
The survey should collect information on many
of the same topics covered in the IDIs. Consider
conducting the survey after the IDIs are completed so that the survey design is informed by the
results from the IDIs. It will also allow program
providers to determine whether the findings from
the IDIs are present in a larger sample of providers. Given that this population is likely to have
high literacy levels, surveys can be self-administered. The sample size for the survey will depend
on the number of facilities capable of offering
PrEP and the number of providers at these sites
in each region of interest to program planners.
One option is to administer the survey to all
providers within a selected number of facilities.
However, consult with a statistician to determine
the sample size needed in order for findings to
be generalizable to a type of service provider and
service deliver setting.
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After the assessment, program planners should
consider conducting a one to two day workshop
with service providers from a variety of service
delivery settings to discuss the findings from
the IDIs and survey. This format is conducive to
building consensus among service providers on
the feasibility of PrEP introduction and allows
participants to work together to develop locally
grounded strategies to build capacity for offering
PrEP. Participants can be divided into breakout
groups to discuss questions about PrEP that
arise. A note taker for each group is important
to record all main points. Following the breakout
sessions, groups should be brought back together to report on their discussion and start the
consensus building process.

Qualitative questions
PrEP knowledge, attitudes and perceptions
• What have you heard about PrEP?
 Have you received any professional or
technical guidance/training regarding
PrEP, from the government or international
organizations? (If yes, please describe)
• What do you see as the potential benefits of
introducing PrEP?
• What concerns, if any, do you have about
introducing PrEP? (Probe on safety, efficacy,
drug resistance, risk compensation)
• Who should have access to this new
intervention?
 Which groups would most benefit from
PrEP?

Questions
A 2012 consultation led by the Population Council on “Shaping the operations research agenda
for antiretroviral-based prevention products for
women” identified several important domains for
operations research relevant to PrEP and service
providers, including service delivery models,
programs and services; providers; type and
training; HIV testing and retesting; and potential
resistance. Several questions presented below
are drawn from this document. We encourage
program planners to access the document
for more detailed information at http://www.
popcouncil.org/uploads/pdfs/2012HIV_ShapingORAgendaARV.pdf.
We also encourage program planners to access
another Population Council resource, “ARVbased HIV prevention for women: State of the
science and considerations for implementation
in Zimbabwe. Report from a provider workshop,”
to aid in designing a workshop with providers
focused on PrEP and applicable questions that
can be included. This resource can be downloaded at: http://www.popcouncil.org/uploads/
pdfs/2015HIV_ZimbabweProviderWorkshop.pdf.

 For each group that would benefit, where
and how would they best be reached?
• Would you feel comfortable prescribing PrEP?
 How might you assess if a patient/client
needs might be a good candidate for PrEP?
• What additional information would you need in
order to feel comfortable prescribing PrEP?
• Based on your experiences, what are your
opinions about making HIV PrEP available for
AGYW?
 How would you feel about prescribing PrEP
to AGYW?
 What do you see as the potential benefits
of introducing PrEP for AGYW?
 What are the drawbacks?
 What additional information would you
need in order to feel comfortable providing
PrEP to AGYW or certain subpopulations of
AGYW?
• Under what circumstances would you
prescribe PrEP to AGYW?
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Legal and ethical considerations
• What type of legal/ethical issues do you
currently encounter when providing HIV
or other types of sexual and reproductive
services to adolescents and young adults?
(Probe on sub-groups of AGYW such as FSWs,
orphans, married AGYW)
 How do you address these issues?
 What actions should policy makers take to
address these issues?
• If in the next year, the government endorsed/
provide PrEP, how would that influence your
opinion of PrEP?
• What legal or ethical issues would consider in
providing PrEP to young women?
 How do national regulations regarding the
provision of ARV-based medications to
AGYW influence your work?
• What are current parental consent laws
around HIV services for young people?
 How would this affect protocols for
providing PrEP to AGYW at your clinic/
health facility?
 Under what circumstances should AGYW be
able to consent for themselves? Why these
circumstances?
 What kind of information do you think
should be provided to partner(s) or
parent(s)/guardian(s) of AGYW who are on
PrEP or seeking PrEP?
 What is the obligation of the health care
provider in reaching the AGYW’s sexual
partner(s) or parent(s)/guardian(s)?
• How do you think community leaders would
respond to the introduction of PrEP for AGYW?
What about religious leaders or institutions?
Schools? Other groups?

• What cadre of staff (i.e., nurse, clinical officer,
health worker) would best be able to screen,
counsel, and prescribe PrEP to AGYW?
 At your clinic/health facility, what kinds of
trainings might be needed on the provision
of PrEP? And on being able to provide PrEP
to AGYW?
• At your clinic/health facility, how would
providing PrEP affect existing services in terms
of client flow, operations, staffing, storage,
etc.?
• What do you foresee as the key challenges
providers may face in offering PrEP? And in
offering PrEP for AGYW?
• How can you support women’s use of the PrEP
or other daily ARV-based medication? In what
ways do you help women understand and
manage potential side effects?
• How do you/your clinic, currently measure/
assess if clients are adhering to their ARV
medications?
 What challenges would AGYW face in
adhering to PrEP?
• In your experience, what strategies have been
effective for supporting adherence among
PrEP users?
• What are the storage implications for PrEP at
the service delivery site?
• What service model package is most effective
for reaching various sub-populations of AGYW?
• Which program entry points would be most
effective to deliver PrEP?
 ARV-based prevention products will require
counseling, HIV testing, and monitoring.
Which service settings might afford good
opportunities for delivering PrEP? (Probe on
existing settings in the country)

Service delivery considerations

Service access and quality

• What do you consider appropriate service
delivery settings to offer PrEP to AGYW?

• What are the main challenges that AGYW
might face in getting access to PrEP?
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• How well do you feel your clinic/health facility
is currently doing in providing the following
services, and for each, how can service
delivery be improved?
 Quality of care overall
 Quality of care for HIV-positive patients on
ARVs
 HIV testing and counseling
 Adherence counseling, for ARVs and other
regimes requiring adherence
 SRH services for adolescents
 Welcoming and comfortable environment
for AGYW

age? How they acquired HIV? Reported sexual
activity?
• Why might community groups have negative
reactions to providing PrEP to AGYW?
• Why might health care providers have negative
attitudes about providing PrEP to AGYW?
• How would you describe your feelings about
prescribing PrEP to AGYW? Would this differ by
the client’s age (girls age 10–14 vs. 15–19 vs.
20–24), and if so, how?
• How do you think you would react if an AGYW
client requested PrEP?

Quantitative questions

• If PrEP was introduced in the country, how
do you think this would affect existing HIV
prevention and treatment programs and the
health system more broadly? (Probe on HIV
testing programs, HIV treatment programs,
sexual and reproductive health programs/
services, staff deployment, task-shifting)

The quantitative survey should collect provider
demographic information to assess whether PrEP
knowledge, attitudes, and experiences differ by
provider demographics, such as age, gender,
medical training, facility type, experience caring
for HIV-positive patients, or perceived HIV risk.

• Are there lessons (positive and negative) from
the introduction of other technologies or HIV
prevention strategies that could inform plans
for introducing PrEP?

PrEP knowledge, attitudes and perceptions/
stigma

• Are there lessons (positive and negative) from
other HIV prevention programs with AGYW that
could inform plans for introducing PrEP for
AGYW?
• In your opinion what might be the best way
to create demand among AGYW for this new
product?
Stigma
• Who do you consider to be the most at risk for
HIV? Why? (Probe on AGYW and sub-groups)
• How well do you think AGYW are able to
assess their level of HIV risk? How do you
counsel youth clients who think they are at
high risk of HIV?
• How do providers currently view AGYW who
take ARVs? Does this differ by the client’s

Response categories for the following questions
are: (a) strongly agree; (b) agree; (c) neutral; (d)
disagree; and (e) strongly disagree.

Provider attitudes and perceptions about
PrEP in general
Note: The questions in this section were adapted from Mimiaga MJ, et al. 2014. “Suboptimal
awareness and comprehension of published
preexposure prophylaxis efficacy results among
physicians in Massachusetts,” AIDS Care 26(6):
684–693.30
1.

There is not enough data on PrEP’s clinical
efficacy

2.

I am concerned about the potential side
effects of PrEP

3.

I do not have time to provide clinical
monitoring
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4.

I do not have time to engage in prevention
counseling

5.

The use of PrEP will cause patients to
engage in riskier behaviors

6.

The provision of PrEP will result in an
increase in sexually transmitted disease
incidence among patients

i.

Any person regardless of risk

Attitudes and perceptions about PrEP for
AGYW
1.

AGYW are at high risk for acquiring HIV

2.

PrEP should be readily available to AGYW

3.

The use of PrEP will result in less frequent
HIV testing among patients

There are certain sub-populations of AGYW
who are at high risk for acquiring HIV

4.

Non-biomedical HIV prevention interventions
(behavioral) are more effective than PrEP

PrEP should be readily available to certain
sub-populations of AGYW

5.

Non-biomedical HIV prevention interventions
(behavioral) are safer than PrEP

The use of PrEP will cause AGYW to engage
in riskier behaviors

6.

10. The use of PrEP for prevention will result in
less funding for HIV treatment

Administering PrEP to AGYW would result in
backlash from the community

7.

11. Antiretrovirals for prevention will select for,
and disseminate, drug resistance

Administering PrEP to AGYW would result in
backlash from religious leaders

8.

I would provide PrEP to the following subpopulations of AGYW [record response for
each]

7.
8.
9.

12. Non-biomedical HIV prevention interventions
(behavioral) should be attempted before
prescribing PrEP

a. AGYW with a sexually transmitted
disease

13. I am uncomfortable prescribing drugs for
new indications unless there are many years
of follow up data

b. AGYW who change sex partners
frequently

14. I believe PrEP should be readily available to
all persons at risk for HIV infection

c. AGYW who exchange sex for money,
drugs or other goods

15. I would provide PrEP to the following subpopulations [record response for each]

d. AGYW with an HIV-positive partner

a. High-risk men who have sex with men

e. Any AGYW who believes she is at high
risk for HIV infection

b. Injection drug users

f.

c. People with a sexually transmitted
disease

Any AGYW regardless of risk

Stigma

d. People who change sex partners
frequently

1.

Providing PrEP endorses the negative
(sexual) risk behaviors of users

e. People who exchange sex for money,
drugs or other goods

2.

PrEP should not be given to AGYW because
they should not be having sex

f.

3.

AGYW are not responsible enough to be able
to adhere to PrEP

4.

AGYW should be ashamed to ask their
provider for PrEP

AGYW

g. Discordant couples
h. Any person who believes he/she is at
high risk for HIV infection
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5.

Parents should be ashamed if their young
daughters ask their provider for PrEP

Service Delivery Considerations/Service Access
and Quality
1.

What do you consider appropriate service
settings to deliver PrEP to AGYW? [Check all
that apply]
• Public sector health centers

to provide information about PrEP that are
appropriate for AGYW
4.

Providers counsel clients about HIV testing
and repeat testing, HIV prevention options,
including male and female condoms, and
provide instructions on use, side effects and
follow-up required

5.

Providers emphasize the importance of
condom use as the best available means for
HIV prevention and encourage use of male
and female condoms along with PrEP

6.

Facilities have the necessary equipment and
supplies to provide PrEP (including HIV test
kits, PrEP, male and female condoms, other)
and have a system to prevent stock outs

7.

The facility provides a private space for
confidential HIV testing and counseling
on PrEP use, and providers ensure client
privacy and confidentiality

8.

Providers tailor interactions to each AGYW’s
particular needs, circumstances and
concerns

9.

Providers treat AGYW with dignity and
respect; they are non-judgmental and
sensitive to gender differences and power
imbalances

• Private health centers
• Non-governmental organizations
• Faith-based organizations
• Youth-friendly health service locations
• HIV counseling and testing sites
• STI prevention and treatment sites
• Family planning and reproductive health
sites
• Maternal health settings
• Gender-based violence counseling sites
• Mobile health services
• Other [please write]

Checklist for service delivery readiness
Note: The questions below can be thought of as a
checklist to determine the readiness of a service
delivery site to introduce PrEP for AGYW.
Please respond to the following statements,
thinking about your own service setting/facility.
Response categories for the following questions
are: (a) strongly agree; (b) agree; (c) neutral; (d)
disagree; and (e) strongly disagree.
1.

Written medical guidelines, protocols
and standards for ARV-based prevention,
including PrEP, are available at this site

2.

Providers have been trained in the provision
of PrEP to AGYW

3.

Providers have job aids and information,
education and communication materials

10. Providers use language that clients,
including AGYW, understand, assess
knowledge gaps, and encourage questions
to check comprehension of information
provided
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MALE PARTNERS OF AGYW
Engaging male partners of AGYW is important in
understanding the likelihood of PrEP acceptance,
uptake, and adherence by AGYW. Gender norms
and the gendered division of power often result
in male partners exerting influence over women’s
decisions about their sexual and reproductive
health. Therefore, PrEP introduction efforts need
to engage AGYW’s male partners to understand
the norms and decision-making processes within
their relationships, their knowledge and perceptions of PrEP, and their attitudes and concerns
toward AGYW’s use of PrEP.

Population
Men’s influence on women’s decision-making
processes regarding their sexual and reproductive health differs by partner type. Research from
several microbicide trials found that women reported better adherence and greater ease using
products discretely with “casual,” transactional,
and non-cohabitating partners compared to
steady/main partners.25 Given the challenges of
using HIV prevention interventions in more stable
partnerships, we recommend that husbands, cohabitating partners, and boyfriends be the focus
of the assessment.

Key Domains
PrEP Attributes, Knowledge and Perceptions:
One of the reasons why men might be opposed
to their partners using sexual and reproductive
health products is their concerns about product
safety.25 Resistance is also fueled by lack of
knowledge about the product. Therefore, efforts should be made to elicit their opinions and
perceptions regarding PrEP, which can aid in tailoring messages that gain men’s support of their
partners’ use of PrEP.23

Gender Norms and Power Dynamics: Research
shows that prevailing gender norms about
sexuality and relationship dynamics affect how
women make decisions about the use of sexual and reproductive health products, including
microbicides, condom use, and contraceptive
use.2,20,22,23,25 For example, partner opposition
has been identified as an important reason
for contraception misuse and that emotional,
physical, and sexual violence within relationships significantly reduces contraceptive use
and continuation.22,25 Furthermore, the choice
to use sexual and reproductive health products
could have a negative impact on the relationship
because some men may equate their usage with
infidelity.25 Program planners should assess how
gender norms and power dynamics influence
men’s acceptance and support of their partner’s
use of PrEP.

Methods
We recommend the use of IDIs to gain information on male partners’ knowledge, attitudes,
beliefs, and concerns about PrEP and their
partners’ use of it. IDIs are preferred due to the
sensitive nature of the questions. A minimum of
four to six IDIs should be conducted per relationship type—married, co-habitating, and boyfriend.
IDIs should consider the HIV status of the male
partner, as HIV positivity may influence men’s
attitudes toward PrEP. Program planners must
also consider regional variations which require a
similar number of IDIs for each distinct area.
Recruiting a selection of male partners could
be done through their female partners (though
there are ethical challenges to consider), through
community groups, and through locations where
they are known to frequent (e.g., local bars or
work venues). One type of location to find AGYW
who might have a steady/main partner is health
care settings, especially antenatal care and
family planning service locations. AGYW might be
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able to directly recruit their partners or they can
provide the locations (e.g., home address) where
to reach them. It is vitally important that program
planners make sure that AGYW are comfortable
recruiting their male partners or providing information. Another avenue to recruit male partners
is to directly approach them in locations where
they are known to frequent. These locations can
be identified through their female partners and
from key informants, such as staff at NGOs who
work with men and are knowledgeable of the
local scene. HIV-positive male partners can be
recruited through health services, such as those
offering services to discordant couples.

 Which groups would most benefit from
PrEP?
 For each group that would benefit, where
and how would they best be reached?
• What are the best ways to engage men
regarding PrEP?
 What information should be included in
education and sensitization campaigns
about PrEP geared toward male partners?
• What about you, are you interested in taking
PrEP? Why or why not?
• What do you think about AGYW having access
to PrEP?

Recruit and train male facilitators from the region
where the IDIs will take place because they will
be knowledgeable and aware of the gender
norms and beliefs in that area. Furthermore,
being interviewed by peers who are familiar
with local norms will build rapport between the
facilitator and participants, encouraging honest
answers from participants.

Gender norms and power dynamics

Questions

• How might you discuss your desire to start
taking PrEP with her?

PrEP attributes, knowledge, and perceptions

• If your sexual partner told you that she wanted
to take PrEP, what would be your reaction?

• Had you heard about PrEP before today? If
so, what had you heard, and from who or
where did you hear it? (Probe for health care
provider, friend, community-based educator,
PrEP user)
• Based on what you learned today/have heard
before, what are your thoughts about PrEP?
 What concerns do you have about PrEP?
(probe on safety, stigma, taking a drug if
HIV-negative, side effects, relationship
concerns, community influences)
 What questions do you have about PrEP?
• Who do you think should have access to this
new intervention?

• Please tell me about instances where you
have discussed avoiding/preventing HIV
with your primary sexual partner? (Probe on
condom use, male circumcision)
• How do you think your opinion affects the
decisions your sexual partner makes about
using products to prevent HIV and pregnancy,
such as condoms or contraceptives?

 What would you do?
 What would say? Would you support her
 How would your opinion affect her decision
to take PrEP?
 What are the best ways for your partner to
engage you about her desire to take PrEP?
• What would be some reasons why your sexual
partner would not tell you she was interested
in taking PrEP or she was taking PrEP?
• If you found out that your sexual partner was
taking PrEP and she had not told you, what
would be your reaction?
 What would you do?
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 What would you say?
• If your partner decided to take PrEP, what
impact might her decision have on your
relationship?
• If your partner wanted to take PrEP, what can
be done to gain your support for her decision?
• If your partner decided to take PrEP, what
things would you do to support her decision?
 Would you participate in drug-adherence
counseling? Why or why not?
 What are the main barriers to you
accompanying your partners to the clinic for
PrEP?
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PARENTS AND GUARDIANS OF
AGYW
Parents’ and guardians’ knowledge, attitudes,
and perceptions about PrEP may directly influence those of AGYW. This is particularly important
to examine in places where the ability to use
PrEP by AGYW under the legal age of consent is
dependent on obtaining a parent’s or guardian’s
consent. Obtaining parental or guardian consent
can be a significant barrier, either because they
cannot be reached or because they may decline
consent. To determine the feasibility of PrEP for
AGYW, especially those who are under the legal
age of consent for medical treatments (which
varies by country), this section provides guidance
on engaging parents and guardians in the assessment process.

Population
AGYW reside in different types of family structures, where guardians might have varying
opinions about their use of medical interventions.
Research shows that family structure influences
adolescent beliefs as well as health and education outcomes.26,27 Understanding how different
type of guardians view PrEP for AGYW will aid in
tailoring introduction strategies. Examples of family structures to consider appear in Box 4.

Key Domains
PrEP Attributes, Knowledge and Perceptions:
Parents and guardians may be reluctant to
provide consent for their adolescent to take PrEP
because they lack knowledge about it and have
safety concerns related to taking the drug.28 Without proper information, they might overestimate
the risks of adverse health events associated
with taking PrEP. Efforts should be made to
educate parents and guardians about PrEP and
its attributes, especially information about safety,

BOX 4
Potential family structures
Two parent households
Single parent households
Grandparent-headed households
Households headed by other relatives
Household headed by non-relatives
Households with orphans
AGYW living in government facilities

and elicit their opinions regarding PrEP. This information can aid in tailoring messages that foster
parents’ and guardians’ support for PrEP.
Stigma and Social Acceptability: As previously
noted, the willingness of AGYW to use and adhere
to PrEP will greatly depend on social understandings, including whether it is seen as an effective,
healthy, and socially acceptable strategy for HIV
prevention among AGYW.21 Parents’ and guardians’ understanding and acceptance of PrEP may
play a key role in providing AGYW with support or
formal consent to take PrEP, as well as influence
AGYW’s uptake and adherence to PrEP. However,
the stigma associated with taking an ARV medication may result in parents’ and guardians’
reluctance to provide their consent. Parents may
be concerned about the backlash their child and
their entire family might face (e.g., belief that
their child is HIV-positive) if the community finds
out and is not accepting of PrEP.28 Introducing
PrEP to AGYW, especially those under age 18 (or
the legal age of consent), requires understanding the role of stigma and acceptability from the
perspective of parents and guardians.
Legal and Ethical Considerations: Many ethical and legal considerations pose a significant
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challenge to providing PrEP to AGYW. The need
for adult consent in some settings may act as a
deterrent for AGYW in accessing health services
due to the need to disclose their behaviors to
their parents or guardians.10 However, a prevailing question is whether parents and guardians
think it is necessary for them to provide consent.
Even if parents and guardians think their consent is necessary, there might be circumstances
in which their consent can be waived. There is
a need to understand these ethical and legal
complexities from the viewpoint of parents and
guardians if PrEP will be feasible for AGYW under
the legal age of consent.

Methods
Use FGDs to elicit in-depth information on parents’ and guardians’ knowledge, attitudes, and
perceptions about PrEP and considerations
around providing consent for their adolescent
child to use PrEP. For each chosen family structure type, an ideal focus group size is between 6
and 10 participants, with at least 2–3 groups of
participants. Program planners must also consider if groups should be conducted in various
regions, which will require a similar number of
FGDs (one to two) per chosen area. It is recommended that trained facilitators from the
community conduct the FGDs because these
individuals will be knowledgeable of local norms
and will be able to build rapport with parents.
One avenue for reaching parents is through
institutions that service adolescents and/or
guardians, such as schools, churches, and social
service organizations. For example, teachers
in schools can provide information on potential
guardians to recruit. Another avenue is to partner with local NGOs who work with families or
are familiar with families in their communities.
The staff of these organizations can identify the
households and aid in recruitment.

Questions
PrEP attributes, knowledge and perceptions
• Had you heard about PrEP before today? If so,
what had you heard, and who or where did
you hear it? (Probe for health care provider,
community-based educator, another parent or
guardian, PrEP user)
• Based on what you learned today/have heard
before, what are your thoughts about PrEP?
 What concerns do you have about PrEP?
 What questions do you have about PrEP?
• Who do you think should have access to this
new intervention?
 Which groups would most benefit from
PrEP?
 For each group that would benefit, where
and how would they best be reached?
• What do you thinking about adolescents
and young people having access to this
intervention? Should PrEP be a choice for
youth?
 What about girls?
 At what stage in life do you think girls
should be able to access PrEP?
 What about boys?
• Have you ever discussed HIV prevention with
your sons or daughters?
• If your daughter wanted to take PrEP or you
found out that your daughter was taking PrEP,
what would be your reaction to this news? Why
would this be your reaction?

Stigma and social acceptability
• Who do you consider to be the most at risk for
HIV? Why?
 What about AGYW and sub-groups (List
the various sub-groups of AGYW if not
discussed)
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• What do you think parents like yourself think
about adolescent girls who engage in sexual
activity?
• Do you think AGYW are able to assess their
HIV risk?
• How do other adults in the community, who
are like you, view AGYW who take ARVs
currently?
 How would you think they would view those
who take PrEP?
 How do you think they would view you if
they knew your child was taking PrEP?
• Sometimes, people who are taking ARVs face
negative attitudes or reactions from health
care providers or from other community
members; what drives these attitudes or
reactions?

Legal and ethical considerations
Note: These questions should be tailored based
on the legal and ethical guidelines within each
country.
• Currently, parents/guardians must give
adolescents under the age of [insert relevant
age] their permission to access [insert
relevant services] and use [insert relevant
products]. Under what circumstances do you
think parents in your community would give
their adolescents permission to access these
services or use these products?
 What has been your other parents’
experience with offering permission for
services?

• If your daughter wanted to take PrEP or you
found out that your daughter was taking PrEP,
what would be your reaction to this news? Why
would this be your reaction?

• Currently, parents/guardians must give
adolescents under [insert relevant age] their
permission to access [insert relevant services]
and use [insert relevant products]. If policy
makers decide that adolescents no longer
require parental permission to access these
services or use these products, what would
be your reaction? Why would you have such a
reaction?

• If your daughter wanted to take PrEP or you
found out that your daughter was taking PrEP,
what kind of support would you offer to her?

• What about PrEP, do you think parental
permission should be required in order for
adolescents to use PrEP? Why or why not?

 What might be the best way of addressing
these issues to reduce negative attitudes
and reactions?

 Would you be willing to attend adherence
counseling with your adolescent? Why or
why not?
• What should be done to inform parents about
PrEP? What will gain your support if you are
reluctant about your daughter taking PrEP?
 What information should be included in
education and sensitization campaigns
about PrEP geared toward parents?
• What cultural traditions might impact AGYW
decision to use PrEP? How about to not use
PrEP?

• Under what circumstances do you think
that your adolescent does not need your
permission to access [insert relevant services]
and use [insert relevant products]? What
about PrEP, specifically?
• If your daughter wanted to take PrEP, would
you be willing to give your permission for her
to take it?
 What are the main reasons why you would
not give your consent?
 What are the main reasons why you would
give your consent?
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POLICY MAKERS
Understanding policy makers’ awareness, attitudes, perceptions, and preferences around
PrEP is very important in guiding its introduction
and roll-out. It is also important to understand
their vision for how PrEP fits into the overall HIV
prevention landscape in their countries and their
opinions about drug availability, prioritization of
populations, settings for PrEP roll-out, tailoring
services to foster effective uptake of PrEP, and
ensuring adherence.4
To engage policy makers around PREP and
AGYW, we recommend the toolkit, “Introducing
antiretroviral (ARV)-based prevention products
for women: a guide to strategic decision-mak-

ing and planning.” With the support of USAID/
Washington, the Population Council developed
the toolkit (http://www.popcouncil.org/uploads/
pdfs/2015HIV_ARVtoolkit.pdf) for use by governments, organizations, and donors that are in a
position to support or add new HIV prevention
products into existing programs. This toolkit is
based on the belief that women should have
access to a wide range of options to prevent
HIV and have the ability to choose those that
best meet their needs. The toolkit was piloted in
Zimbabwe and a document containing the results
along with additional resources can be downloaded at http://www.popcouncil.org/uploads/
pdfs/2015HIV_ZimbabweProviderWorkshop.pdf.
Box 5 summarizes three of the toolkit’s modules.

BOX 5
Toolkit modules
Module 1. Landscape analysis
An analysis of the epidemiologic context of the HIV epidemic, along with an HIV policy and
program scan. The analysis consists primarily of a desk review of available literature and data,
supplemented as needed with input from experts familiar with the HIV epidemic and the specific
country context. It serves as a starting point and foundation for the process in Modules 2 and 3.
Module 2. Discussion guide for key opinion leaders and decisionmakers
A guide to conducting IDIs with a select group of key decision makers who will be involved in
or influence strategic decisions about the introduction and roll-out of PrEP. Key domains to
cover with opinion leaders and policy makers include: scientific evidence and data needs;
target population and priorities; impact on health systems; policy considerations; economics,
cost, and financing; and decision-making. IDIs should be conducted by a senior leader who is
knowledgeable about both HIV prevention and the country’s policy environment. Results will
provide an indication of the strategic role PrEP could play within a country’s HIV prevention
program and help determine how best to continue to explore and plan for introduction.
Module 3. Program planning guide
The guide is to be used with policy makers, service providers, and program managers who
are responsible for implementing HIV prevention programs. The module guides workshop
participants to consider the feasibility of introducing HIV prevention tools in specific facility-based
settings by guiding them through a series of design considerations to determine opportunities
and challenges in service setting(s) that should be addressed in program planning.
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SECTION 3

ADDITIONAL DATA COLLECTION
METHODS
In this document we propose the use of FGDs
and IDIs. FGDs involve a small group of individuals who share common characteristics or
experiences related to the topic of interest.33
The group dynamic allows for brainstorming to
generate insights and strategies, provides information on social context such as norms, and gain
insights into social interactions. IDIs, on the other
hand, are one-on-one discussions between a participant and an interviewer.34 The interview can
be semi-structured with open-ended questions
or unstructured allowing the participant to freely
discuss the topic. IDIs provide rich, detailed information from participants about their experiences,
opinions, and behaviors. They are particularly
useful for sensitive and complex subjects. Key
informant interviews are IDIs with people who are
knowledgeable about what is going the community.

PARTICIPATORY TECHNIQUES
As part of FGDs and IDIs, there are additional
techniques that can be used to get more insight
into participants’ views:
1.

Card-sorting involves creating a set of cards
with descriptions about a topic, problem,
behavior, or product. The descriptions can
be pictorial or text. The cards are given to
the participant who is asked to sort them
in a particular order. For example, the

researcher might ask AGYW to sort cards
on PrEP characteristics and attributes
according to what most concerns them
about PrEP or what would most influence
their decision to take PrEP. After the
sorting is complete, the researcher can ask
participants questions to further explain
their thought process for the order they
selected. Card-sorting can be incorporated
into qualitative study designs previously
discussed. For example, participants can
complete a card-sorting activity at the end of
the FGD.
2.

Vignettes are stories created by researchers
about individuals and situations to help
elucidate participants’ perceptions, beliefs
and attitudes about a topic under study.35,36
The premise of the stories comes from
a range of sources, including previous
research findings, research participants, and
information from key informants in the field
such as NGO staff working with the research
population. It is important that the vignettes
are relevant and real to the participants.
The vignettes are presented to participants,
who are asked to respond to a range of
questions about what they have heard,
including what they would do in a particular
situation or how they think another person
would respond. It is particularly useful
when interviewing young children and
adolescents. One of the key limitations is
that vignettes cannot account for what a
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participant will actually do in real life but it
is helpful for unpacking perceptions, beliefs,
and attitudes on a wide range of social
issues.

OBSERVATIONS
Observation involves the careful and systematic
documentation of events and behaviors in the social setting chosen for study. The observer makes
detailed field notes that are nonjudgmental and
concrete in descriptions.37,38 Notes should include
descriptions of actions and interactions among
individuals as well as non-verbal cues such as
body language and facial expressions. After
initial observations, checklists can be created to
assess the presence or absence of a phenomenon. One limitation to this method is reactivity by
those being observed; individuals might change
their behaviors when they know they are being
observed. One solution is to visit the site for a few
days before data collection to reduce reactivity.
Program planners can directly observe the clinical settings in which PrEP is likely to be offered
as well as current interactions between providers
and AGYW patients to understand service delivery areas that work well and areas requiring
improvement. For example, observing interactions surrounding contraceptive use can serve as
a proxy for PrEP. This information can be used to
prepare a clinical setting for PrEP introduction,
such as trainings of health care providers. Following the introduction of PrEP, observations can
be conducted to understand how well the setting
was prepared, successful implementation strategies, and ongoing challenges.

order to evaluate client experience when seeking
services, such as health care.39-41 The method reduces the bias that can be introduced in
observations; that is, where individuals change
their behaviors because they know they are
being observed. Mystery clients are individuals
who possess the characteristics of the types of
patients who would seek the service. Clients are
trained to assume a specific role when seeking
services and then report on their experience.
Immediately following the visit, the client is
interviewed using a checklist or interview guide
in order to capture a detailed account about their
experiences and interactions while in the facility.
It is best that mystery clients do not come from
the area where the clinical setting is located. The
facility should be informed that mystery clients
will visit the facility but not exact dates. For example, facilities can be told mystery clients will visit
within the next three months.
Program planners can use mystery clients during
PrEP introduction to monitor and evaluate service
delivery, including patient-provider interactions,
adherence to delivery protocols, and service
quality. This method can provide detailed and
useful insights into good practices and areas for
improvement.

MYSTERY CLIENT METHOD
The mystery client (or shopper) method involves
researchers posing as prospective clients in
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SECTION 4

DATA ANALYSIS STRATEGIES
QUALITATIVE DATA
Analysis and interpretation of the qualitative and
narrative data proposed in this guidance document should provide unique insights that can
assist in determining the feasibility of introducing
PrEP to AGYW and if feasible, the development,
design, and implementation of PrEP introduction
strategies. This section is not intended to provide
a comprehensive data analysis plan because
there are several good textbooks that can provide
guidance on approaches to qualitative data analysis.29–39 This section, instead, provides practical
advice for conducting qualitative analyses.
Key strategies for analyzing qualitative data
include designing an analysis plan, becoming
familiar with the data, categorizing the data,
identifying patterns and connections within the
data, and interpreting the data. There are several
qualitative data analysis software programs that
can aid in the analysis, including ATLAS.ti, NVivo,
MAXQDA, Dedoose, and QDA Miner. All of these
programs have strengths and weaknesses and
choosing one will depend on the types on analyses that will be performed. Each program has
user-friendly resources to aid in conducting the
analyses.
Recommended strategies for conducting qualitative data analyses:
• Design an analysis plan: A data analysis plan
helps in structuring the analyses and ensuring
all team members are informed of how the
data will be analyzed. Design an analysis plan

that reflects the aims of the data collection
and the questions that program planners are
trying to answer. Program planners might want
to focus the analyses by topic, an event, or
learnings from a group.
• Outline transcription expectations: Data
collected are usually transcribed into written
text for analyses. Good quality transcription is
fundamental to the data analysis process. The
level and detail of transcription will vary and
it is important to outline these expectations
from the beginning. For example, decisions
must be made regarding whether verbal and
non-verbal information should be included.
The decisions on transcription are dependent
on the research aims.
• Start the analysis as data is being collected:
Analyses of qualitative data is an iterative
process that starts during data collection and
continues beyond data collection. As data is
collected, program planners should listen to
recordings and read transcripts on an ongoing
basis in order to understand the quality of
the data and to refine questions and explore
emergent topics not previously considered in
subsequent interviews or group discussions.
Additionally, field notes should include a
summary of the interview and these notes
should be reviewed continually.
• Coding and analysis: The next step in the
analysis process usually involves data
condensation or reduction process, through
coding the data and drafting analytic memos,
pertaining to the major themes emergent from
the data and/or the themes of interest. It is
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important at this stage of the analysis process
to develop a codebook, particularly if multiple
research team members will be involved in
reviewing and coding the data. The codebook
aids in the systematic coding of text. For each
code (theme), the codebook outlines the
name of the code, its definition, guidelines
for when to use and not to use the code,
and examples. Due to the iterative nature of
qualitative data analysis, the codebook can be
refined several times during the analysis.
• Data display: Data display (through matrices,
flow charts, etc.) can assist in assembling
data across themes and respondents to better
elucidate the relationships among themes,
groups of respondents, and categories of
data. This critical step allows for comparison
and contrasting of findings across and within
respondents.
• Assess reliability and validity: It is important
to assess the validity and reliability of findings
to ensure that the findings reflect the reality
of the participants’ lives and that the findings
can be consistent, respectively. Closely
rereading transcriptions, triangulating data
from various sources, and obtaining feedback
from participants are common methods for
assessing reliability and validity.
• Interpretation of findings: One of the most
important steps in qualitative analysis
involves the interpretation of findings,
drawing conclusions, and verification of the
data interpretation. In this final stage, it is
important to contextualize the findings with
existing literature, connect to theory, and
discuss alternate explanations/interpretations
of the data.

SURVEYS
Surveys are a method of gathering information
from a defined group of people to get a broader
understanding of the subject. Surveys mostly

consist of close-ended questions. Traditionally,
surveys have been used to generalize to the
larger population. Surveys allow for large samples and standardized responses. Technology,
when used, increases the ease of survey administration, allowing for quick collection of data
and minimization of errors. Care is needed when
designing surveys and analyzing their results, to
ensure that the right questions are being asked,
the right people are taking the survey, the appropriate number of people of surveyed, and the
results are valid.
Several courses and textbooks can provide
specific quidance on quantitative survey data
analysis.42

Conjoint Analysis
Conjoint analysis, a development of market
research, is a set of techniques used to study
customers’ decision-making processes and
determining tradeoffs.43-45 Conjoint analysis has
the ability to answer various “what if” questions
based on the results of an analysis of data
collected on hypothetical and real choice alternatives. The method uses a survey that outlines
the attributes and characteristics about a product, which is administered to a sample of the
population that the product will eventually target.
Various analytic models, with the assistance of
easy-to-use software, are conducted using the
collected survey data to predict how users will
choose products and services.
Conjoint analysis can be used to elicit potential PrEP users’ views of the drug, including the
importance and trade-offs of different characteristics (e.g., frequency of use, HIV testing
requirement) of the drug. Additional factors that
can be assessed in conjoint analyses include
identifying priority healthcare settings for providing PrEP as well as the relative importance
of different contextual influences (e.g., partner
preferences, stigma) on product views.
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SECTION 5

RESEARCH UTILIZATION
Research utilization is the process by which
research findings are synthesized and disseminated to make an impact on or change in existing
practices. Translating findings into action at the
national, sub-national, and service delivery levels
requires two-way information exchange between
the people who can apply research findings (i.e.,
stakeholders) and researchers or program planners.
Research utilization is a critical component of
the research process and a necessary step for
developing PrEP introduction strategies for AGYW.
In Box 6 (page 34), we highlight seven practices
that increase the likelihood that key stakeholders will promote and utilize study findings and

recommendations to make programmatic and
policy decisions. These practices are drawn from
a guidance document developed by Project SOAR
(Supporting Operational AIDS Research), an
operations research project led by the Population
Council. This document can guide the planning
and implementation for effective research utilization. We recommend program planners and
researchers access the complete resource, “Project SOAR’s research utilization process: guidance
document and toolkit,” at http://www.popcouncil.
org/uploads/pdfs/2016HIV_ProjectSOAR_ResUtilization.pdf.
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BOX 6
Research utilization practices
Practice 1: Identify key stakeholders as early as possible to understand their priority information
needs and establish the audience(s) for the findings. This will enhance the study’s relevance
among those implementing HIV programs and services and development partners investing in
the programs.
Practice 2: Engage stakeholders during study design to ensure that the methods, intervention (if
there is one), and data collection processes reflect and respond to the priorities and needs of the
HIV program and services.
Practice 3: Establish a study-specific advisory panel that assigns roles and responsibilities to
key stakeholders. This will help ensure that stakeholders remain engaged throughout the study
process and will want to champion the use of findings once they become available.
Practice 4: Engage stakeholders during data collection to reinforce their involvement and
deepen their understanding of the research process and what the study is investigating. This
can also help improve fidelity to the intervention under study, if there is one. Engaging key
stakeholders during data collection may motivate them to later use findings and disseminate
them among a wider audience.
Practice 5: Work together with stakeholders to interpret findings and develop recommendations.
Engaging stakeholders permits them to review preliminary analyses and offer insight into the
local program context, which informs specific and realistic recommendations.
Practice 6: Produce the study report and hold the dissemination meeting, during which
stakeholders finalize a plan to use findings and recommendations.
Practice 7: Coordinate the implementation of the plan to use findings and recommendations.
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